Lymphoma Coalition publishes research on the experiences of patients and care partners based on learnings from the Global Patient Survey on Lymphomas and CLL (GPS) and other projects.
It is imperative the issues raised by patients and their care partners through the biennial survey, interviews, focus groups and other initiatives are conveyed to the medical and research communities to improve care moving forward.
[{"id":39998,"link":"https:\/\/lymphoma-stg.clarovantdigital.com\/an-investigation-into-the-preferences-of-patients-regarding-the-use-of-telemedicine-stemming-from-the-covid-19-pandemic\/","name":"an-investigation-into-the-preferences-of-patients-regarding-the-use-of-telemedicine-stemming-from-the-covid-19-pandemic","thumbnail":{"url":"https:\/\/lymphoma-stg.clarovantdigital.com\/wp-content\/uploads\/Patient-Preferences-for-Telemedicine-During-the-COVID19-Pandemic.png","alt":""},"title":"Patient Preferences for Telemedicine During the COVID-19 Pandemic","author":{"name":"","link":"https:\/\/lymphoma-stg.clarovantdigital.com\/author\/firstname lastname\/"},"date":"Jun 11, 2023","dateGMT":"2023-06-11 17:31:00","modifiedDate":"2025-10-14 14:52:48","modifiedDateGMT":"2025-10-14 14:52:48","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/accesstocare\/\" rel=\"category tag\">Access to Care<\/a>, <a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/accesstocare\/barrierstotreatment\/\" rel=\"category tag\">Barriers to Treatment<\/a>, <a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/accesstocare\/covid\/\" rel=\"category tag\">COVID<\/a>, <a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/lc-research\/\" rel=\"category tag\">LC Research<\/a>","space":"<a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/accesstocare\/\" rel=\"category tag\">Access to Care<\/a> <a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/accesstocare\/barrierstotreatment\/\" rel=\"category tag\">Barriers to Treatment<\/a> <a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/accesstocare\/covid\/\" rel=\"category tag\">COVID<\/a> <a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/lc-research\/\" rel=\"category tag\">LC Research<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":2,"sec":13},"status":"publish","excerpt":"Accepted for publication at the EHA 2023 Hybrid Congress in Frankfurt, Germany from 8-11 June 2023. Telemedicine has become increasingly crucial for remote healthcare delivery, with telephone consultation (TC) and video consultation (VC) being two important modalities. However, there is limited knowledge about the preferences and experiences of patients with lymphoma or CLL (chronic lymphocytic leukemia). Understanding patient preferences and experiences is vital for successfully integrating telemedicine into clinical practice beyond the COVID-19 pandemic."},{"id":40016,"link":"https:\/\/lymphoma-stg.clarovantdigital.com\/identifying-factors-that-affect-barriers-to-lymphoma-treatment-during-the-covid-19-pandemic\/","name":"identifying-factors-that-affect-barriers-to-lymphoma-treatment-during-the-covid-19-pandemic","thumbnail":{"url":"https:\/\/lymphoma-stg.clarovantdigital.com\/wp-content\/uploads\/Barriers-to-Lymphoma-Treatment-during-the-COVID-19-Pandemic.png","alt":""},"title":"Barriers to Lymphoma Treatment during the COVID-19 Pandemic","author":{"name":"","link":"https:\/\/lymphoma-stg.clarovantdigital.com\/author\/firstname lastname\/"},"date":"Apr 19, 2023","dateGMT":"2023-04-19 17:44:00","modifiedDate":"2025-10-14 14:58:39","modifiedDateGMT":"2025-10-14 14:58:39","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/accesstocare\/\" rel=\"category tag\">Access to Care<\/a>, <a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/accesstocare\/barrierstotreatment\/\" rel=\"category tag\">Barriers to Treatment<\/a>, <a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/accesstocare\/covid\/\" rel=\"category tag\">COVID<\/a>, <a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/lc-research\/\" rel=\"category tag\">LC Research<\/a>","space":"<a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/accesstocare\/\" rel=\"category tag\">Access to Care<\/a> <a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/accesstocare\/barrierstotreatment\/\" rel=\"category tag\">Barriers to Treatment<\/a> <a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/accesstocare\/covid\/\" rel=\"category tag\">COVID<\/a> <a href=\"https:\/\/lymphoma-stg.clarovantdigital.com\/category\/lc-research\/\" rel=\"category tag\">LC Research<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":3,"sec":7},"status":"publish","excerpt":"Presented at the AACR Annual Meeting in Orlando, Florida 14 \u2013 19 April 2023. Lymphoma Coalition (LC) supports over 80 patient organizations across more than 50 countries. LC's overarching goal is to facilitate a community of patient organizations supporting efforts to help patients with lymphoma receive care and support.\n\nBarriers to accessing treatment therapy for patients with lymphoma are an essential topic across the globe.\n\nLC's biennial Global Patient Survey (GPS) aims to understand the barriers faced by patients with lymphoma in seeking medical attention or accessing treatment. With the added challenge posed by the COVID-19 pandemic, this study aimed to rank the influence of core demographic variables in their ability to predict barriers to lymphoma treatment in 2020 and 2022."}]